MICROPERIMETRY AS A SCREENING TEST FOR HYDROXYCHLOROQUINE RETINOPATHY: The Hard-Risk-1 Study

Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study

JAMA Ophthalmol.

Binenbaum G, Bell EF, Donohue P, Quinn G, Shaffer J, Tomlinson LA, Ying GS; G-ROP Study Group

doi: 10.1001/jamaophthalmol.

Retinal Diseases

Irish National Diabetic RetinaScreen Programme: report on five rounds of retinopathy screening and screen-positive referrals. (INDEAR study report no. 1)

Br J Ophthalmol

Pandey R, Morgan MM, Murphy C, Kavanagh H, Acheson R, Cahill M, McGettrick P, O'Toole L, Hamroush F, Mooney T, Byrne H, Fitzpatrick P, Keegan DJ

doi: 10.1136/bjophthalmol-2020-317508

COMMENTED

Retinal Diseases

Applicability of telemedicine in the screening of diabetic retinopathy (DR): The first multicentre study in Italy. The No Blind Study

Diabetes Metab Res Rev.

Sasso FC, Pafundi PC, Gelso A, Bono V, Costagliola C, Marfella R, Sardu C, Rinaldi L, Galiero R, Acierno C, de Sio C, Adinolfi LE; NO BLIND Study Group

doi: 10.1002/dmrr.3113.

RECOMMENDED

Retinal Diseases

Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study

JAMA Ophthalmol.

Quinn GE, Ying GS, Bell EF, Donohue PK, Morrison D, Tomlinson LA, Binenbaum G; G-ROP Study Group

doi: 10.1001/jamaophthalmol.

Retinal Diseases

Ten-year incidence and assessment of safe screening intervals for diabetic retinopathy: the OPHDIAT study

Br J Ophthalmol.

Chamard C, Daien V, Erginay A, Gautier JF, Villain M, Tadayoni R, Carriere I, Massin P

doi: 10.1136/bjophthalmol-2020-316030.

Retinal Diseases

Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria

JAMA Ophthalmol.

Binenbaum G, Tomlinson LA, de Alba Campomanes AG, Bell EF, Donohue P, Morrison D, Quinn GE, Repka MX, Rogers D, Yang MB, Yu Y, Ying GS, Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group.

doi: 10.1001/jamaophthalmol.

Retinal DiseasesFurther Publications

Higher prevalence of fundus haemorrhages in early-screened (NEST Study) as compared to late-screened (SUNDROP Study) newborn populations

Br J Ophthalmol

Ludwig CA, Jabbehdari S, Ji M, Vail D, Al-Moujahed A, Rosenblatt T, Azad AD, Veerappan M, Callaway NF, Moshfeghi DM

doi: 10.1136/bjophthalmol-2020-317908

Retinal Diseases

Interventions to increase attendance for diabetic retinopathy screening

Cochrane Database Syst Rev.

Lawrenson JG, Graham-Rowe E, Lorencatto F, Burr J, Bunce C, Francis JJ, Aluko P, Rice S, Vale L, Peto T, Presseau J, Ivers N, Grimshaw JM

Blindness and Vision ImpairmentRetinal Diseases

Incidence, timing and risk factors of type 1 retinopathy of prematurity in a North American cohort

Br J Ophthalmol

Yu Y, Tomlinson LA, Binenbaum G, Ying GS, G-Rop Study Group.

doi: 10.1136/bjophthalmol-2020-317467

Related content

Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study

Irish National Diabetic RetinaScreen Programme: report on five rounds of retinopathy screening and screen-positive referrals. (INDEAR study report no. 1)

Applicability of telemedicine in the screening of diabetic retinopathy (DR): The first multicentre study in Italy. The No Blind Study

Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study

Ten-year incidence and assessment of safe screening intervals for diabetic retinopathy: the OPHDIAT study

Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria

Higher prevalence of fundus haemorrhages in early-screened (NEST Study) as compared to late-screened (SUNDROP Study) newborn populations

Interventions to increase attendance for diabetic retinopathy screening

Incidence, timing and risk factors of type 1 retinopathy of prematurity in a North American cohort